Synlogic Provides Corporate Update and Outlook for 2023
Pivotal Phase 3 for SYNB1934 in phenylketonuria (PKU) to initiate in H1 2023 Rare Pediatric Disease Designation received for SYNB1353 for homocystinuria...
Source: globenewswire.com
Page 16 - Synlogic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Synlogic Inc Today - Breaking & Trending Today
Investegate |NMD Pharma Announcements | NMD Pharma: Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors
Investegate announcements from NMD Pharma, Mike Heffernan appointed Chairman of NMD Pharma’s Board of Directors
Source: investegate.co.uk
Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors
Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors Brings 30 years of experience building private and public development-stage and commercial biopharmaceutical companies and has overseen
Source: finanznachrichten.de
Global Microbiome Therapeutics Market Report 2022: Featuring 4D Pharma, Enterome, Finch Therapeutics, Vedanta Bioscience & More
/PRNewswire/ -- The "Global Microbiome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (FMT...
Source: prnewswire.com
Worldwide Crohn's Disease Therapeutics Industry Report 2022: by Drug Class, Gender, Disease Type, Age Group and Geography
/PRNewswire/ -- The "Crohn's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis" report has been added to ResearchAndMarkets.com's...
Source: prnewswire.com